Journal of Anaesthesiology Clinical Pharmacology (Aug 2024)

Target-controlled infusion – Past, present, and future

  • Prasanna Udupi Bidkar,
  • Ankita Dey,
  • Protiti Chatterjee,
  • Rajasekar Ramadurai,
  • Jerry Jame Joy

DOI
https://doi.org/10.4103/joacp.joacp_64_23
Journal volume & issue
Vol. 40, no. 3
pp. 371 – 380

Abstract

Read online

Target-controlled infusion (TCI) is a novel drug delivery system wherein a microprocessor calculates the rate of drug to be infused based upon the target plasma or effect site concentration set by the operator. It has found its place in the operation theaters and intensive care units (ICUs) for safe administration of intravenous anesthesia and analgosedation using drugs like propofol, dexmedetomidine, opioids, and so on. Operating a TCI device requires the user to have a primitive understanding of drug pharmacokinetics and pharmacodynamics and an awareness of the practical problems that can arise during its administration. Ongoing research supports their usage in other clinical settings and for various other drugs such as antibiotics, vasopressors, and so on. In this article, we review the underlying principles and commonly used drugs for TCI, the practical aspects of its implementation, and the scope of this technology in future. TCI technology is increasingly being used in the field of anesthesiology and critical care due to the myriad advantages it offers when compared to manual infusions. It is, therefore, essential for the reader to understand the relevant principles and practical aspects related to TCI technology, as well as to be aware of the commonly used TCI models.

Keywords